Tech Center 1600 • Art Units: 1632 1636 1678
This examiner grants 57% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18257838 | ANTITHROMBIN HEPARAN SULFATE FOR DETECTION AND TREATMENT OF CANCER | Non-Final OA | The Regents of the University of California |
| 17642374 | BIOMARKERS FOR AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND MOTOR NEURON DISEASES | Final Rejection | Northwestern University |
| 18263899 | METHODS OF ADJUSTING THE PH OF A CELL CULTURE MEDIUM | Non-Final OA | Bayer HealthCare LLC |
| 17205649 | COMPOSITE PARTICLE FOR IMMUNOCHROMATOGRAPHY, METHOD FOR MANUFACTURING THE SAME, AND IMMUNOCHROMATOGRAPHY | Final Rejection | FUJIFILM Corporation |
| 17612919 | LINKED BODY FOR FLUORESCENT LABELING AGENTS | Non-Final OA | Konica Minolta, Inc. |
| 17339889 | SYSTEMS AND METHODS FOR ANALYTE DETECTION USING ELECTROMAGNETICALLY INDUCED RESONANCE | Final Rejection | The Brigham and Women's Hospital, Inc. |
| 15963271 | DIAGNOSING MULTIPLE SCLEROSIS | Final Rejection | Oxford University Innovation Limited |
| 17288849 | COMPOSITIONS AND METHODS FOR SELECTING BIALLELIC GENE EDITING | Non-Final OA | United States Government As Represented By The Department of Veterans Affairs |
| 17963376 | NANOZYME LINKED BIOASSAY AND ASSOCIATED METHODS | Non-Final OA | Washington State University |
| 17606981 | Elucidating a Proteomic Signature for the Detection of Intracerebral Aneurysms | Non-Final OA | Icahn School of Medicine at Mount Sinai |
| 18270157 | OPTOELECTRONIC CHIP | Non-Final OA | INTERHERENCE GMBH |
| 18192286 | UVEAL MELANOMA TREATMENT USING SEA-CD40 | Non-Final OA | Seagen Inc. |
| 17998691 | DETERMINATION OF DISEASE-SPECIFIC PROTEIN AGGREGATES IN STOOL SAMPLES | Non-Final OA | FORSCHUNGSZENTRUM JUELICH GMBH |
| 18185632 | PVRL2 AND/OR PVRIG AS BIOMARKERS FOR TREATMENT | Non-Final OA | Compugen Ltd. |
| 18127887 | IMAGE QUANTIFICATION SYSTEM FOR ESTIMATION OF VIRAL LOAD BASED ON DETECTION BY RAPID ANTIGEN TEST | Non-Final OA | Hai Kang Life Corporation Limited |
| 18024620 | MARKERS FOR PREDICTING CORONAVIRUS DISEASE 2019 (COVID-19) IMMUNE CHECKPOINT STORM, APPLICATION AND KIT THEREOF | Non-Final OA | Beijing Immupeutics Medicine Technology Limited |
| 17160196 | METHODS FOR DEPLETION AND ENRICHMENT | Final Rejection | Veravas, Inc. |
| 18159857 | FLUORESCENCE COUNTING SYSTEM FOR QUANTIFYING VIRUSES OR ANTIBODIES ON AN IMMOBILIZED METAL SUBSTRATE BY USING AN ANTIGEN-ANTIBODY REACTION | Non-Final OA | MYTECH CO. LTD. |
| 17754313 | BIOMARKERS FOR ASSESSING EXPLANT ORGAN VIABILITY | Final Rejection | University of Newcastle Upon Tyne |
| 17996478 | HIGH-THROUGHPUT SEROLOGY ASSAY | Non-Final OA | INANOVATE, INC. |
| 17996182 | METHOD FOR ENRICHING EXOSOMES | Non-Final OA | THERAWIS DIAGNOSTICS GMBH |
| 17294931 | ANTIBODY CONJUGATE | Non-Final OA | FUJIREBIO INC. |
| 17628749 | Apparatus and Method for Testing the Health Condition of Animals and/or Human Beings | Final Rejection | ProTEM Services Limited |
| 17620425 | A METHOD FOR DETECTING AN ANALYTE | Non-Final OA | Psyros Diagnostics Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy